Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Santa Rosa
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Santa Rosa, CA

Studies commonly pay $75 to $4,500 per completed study

149 clinical trials are currently recruiting participants within 30 miles of Santa Rosa. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

149studies recruiting
8+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Santa Rosa right now

Top 25 of 149 recruiting studies, sorted by proximity — each links to its official registry page

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Head and Neck Carcinoma, Adenoid Cystic Carcinoma Phase 1, Phase 2 Interventional 242 participants sought
Providence Medical Foundation (site 209) — Santa Rosa, California (0.6 mi) · Sponsor: VM Oncology, LLC

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,900 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Breast Neoplasms, Neoplasm Metastasis Phase 3 Interventional 800 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Eli Lilly and Company

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi) · Sponsor: National Cancer Institute (NCI)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 Phase 3 Interventional 1,875 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Solid Tumor, Non-Small Cell Lung Cancer Phase 1, Phase 2 Interventional 340 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Inhibrx Biosciences, Inc

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Complex Regional Pain Syndrome Type I Phase 3 Interventional 270 participants sought
Ambros Clinical Trial Site — Napa, California (25.0 mi) · Sponsor: Ambros Therapeutics, Inc.

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma Phase 2, Phase 3 Interventional 982 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: Pfizer

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

Renal Pelvis and Ureter Urothelial Carcinoma Phase 2, Phase 3 Interventional 131 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Obesity, Heart Failure Phase 3 Interventional 5,610 participants sought
NorthBay Clinical Research — Santa Rosa, California (0.6 mi) · Sponsor: Novo Nordisk A/S

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: SWOG Cancer Research Network

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,500 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Phase 2 Interventional 156 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: National Cancer Institute (NCI)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: Canadian Cancer Trials Group

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung Phase 2 Interventional 480 participants sought
Providence Medical Foundation 1 — Santa Rosa, California (0.6 mi) · Sponsor: Janssen Research & Development, LLC

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Metastatic Breast Cancer Phase 3 Interventional 600 participants sought
Providence Medical Foundation - Santa Rosa, CA — Santa Rosa, California (0.6 mi) · Sponsor: LeonaBio

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi) · Sponsor: NRG Oncology
Actively enrolling

Studies you may be able to join near Santa Rosa

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Santa Rosa

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Providence Medical Group Santa Rosa - Clinical Trials

3555 Round Barn Cir, Santa Rosa, CA 95403
(707) 521-3830

Siyan Clinical Corporation

★ 4.8 (564 reviews)
480 Tesconi Cir Ste B, Santa Rosa, CA 95401
(707) 206-7268

TrueNorth Health Center

★ 4.4
1551 Pacific Ave, Santa Rosa, CA 95404
(707) 586-5555

Santa Rosa Behavioral Healthcare Hospital

★ 2.2 (244 reviews)
1287 Fulton Rd, Santa Rosa, CA 95401
(707) 800-7700
"Everyone that works there (except for the kitchen staff) knows how to treat people and do their best even when others (patience) are not trying to he…"
— Lamar Manuel, 5★

Sunwise Clinical Research

★ 4.7
1371 Oakland Blvd #301, Walnut Creek, CA 94596
(925) 298-5147
"They are a great group of people"
— Tree Sap, 5★

Evolve Restorative Center

★ 4.1 (53 reviews)
220 Concourse Blvd, Santa Rosa, CA 95403
(844) 527-7369
"First time I've been to this practice....and it will be my last. Looks like a nice facility but staff are robotic and appear to care less about thei…"
— Mike Antill, 1★

Oakland Clinical

3300 Webster St #1106, Oakland, CA 94609
(510) 817-2000

CPMC Research Institute

★ 5.0
2330 Clay St, San Francisco, CA 94115
(415) 561-1785

Clinical trials in Santa Rosa: what's recruiting

The Santa Rosa area currently has 149 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Santa Rosa, the most active research areas are:

  • Cancer & Oncology20 studies
  • Liver & Kidney3 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Santa Rosa, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Santa Rosa

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Santa Rosa participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Santa Rosa pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Santa Rosa safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Santa Rosa, CA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Santa Rosa?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Santa Rosa typically complete one or two studies per year.

Paid clinical trials near Santa Rosa

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of CA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts